amodiaquine hydrochloride has been researched along with chloroquine in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.67) | 18.2507 |
2000's | 22 (48.89) | 29.6817 |
2010's | 20 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harrison, AC; Hawley, SR; O'Neill, PM; Park, BK; Storr, RC; Ward, SA | 1 |
Bray, PG; Hawley, SR; O'Neill, PM; Park, BK; Storr, RC; Ward, SA; Willock, DJ | 1 |
O'Neill, PM; Park, BK; Raynes, KJ; Stocks, PA; Ward, SA | 1 |
Debreu-Fontaine, MA; Delarue, S; Girault, S; Grellier, P; Labaeïd, M; Maes, L; Sergheraert, C | 1 |
Bickley, JF; Bray, PG; Hindley, S; Hughes, RH; Maggs, JL; Mukhtar, A; O'Neil, IA; O'Neill, PM; Park, BK; Randle, LE; Stocks, PA; Storr, RC; Ward, SA; Winstanley, PA | 1 |
Altarelli, M; Basilico, N; Butini, S; Campiani, G; Fattorusso, C; Fattorusso, E; Gemma, S; Kukreja, G; Persico, M; Romano, MP; Savini, L; Taramelli, D; Yardley, V | 1 |
Harada, S; Huy, NT; Kamei, K; Maeda, A; Oida, T; Trang, DT; Uyen, DT | 1 |
Adagu, IS; Fivelman, QL; Warhurst, DC | 1 |
Delarue-Cochin, S; Grellier, P; Maes, L; Melnyk, P; Mouray, E; Paunescu, E; Sergheraert, C | 1 |
Anstey, NM; Brockman, A; Chalfein, F; Cheng, Q; Kenangalem, E; Piera, K; Prasetyorini, B; Prayoga, P; Price, RN; Russell, B; Sugiarto, P; Suwanarusk, R; Tjitra, E | 1 |
Delarue-Cochin, S; Grellier, P; Maes, L; Melnyk, P; Mouray, E; Sergheraert, C | 1 |
Becker, K; Davioud-Charvet, E; Friebolin, W; Furrer, J; Jannack, B; Lanzer, M; Oeser, T; Sanchez, CP; Wenzel, N; Yardley, V | 1 |
Fitos, I; Mády, G; Visy, J; Zsila, F | 1 |
Egan, TJ; Hoppe, HC; Joiner, KA; Roberts, L | 1 |
Amewu, R; Bongard, E; Charnaud, S; Davies, J; Ellis, GL; Gargallo, D; Gibbons, P; Hall, C; Jesús, M; Lozanom, S; O'Neill, PM; Rimmer, K; Sabbani, S; Shone, A; Stanford, D; Stocks, PA; Vivas, L; Ward, SA | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
Anstey, NM; Chalfien, F; Hasugian, AR; Kenangalem, E; Marfurt, J; Penttinen, PM; Piera, KA; Price, RN; Purba, HL; Ratcliff, A; Russell, B; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
Bambal, RB; Bates, M; Berry, N; Biagini, GA; Bonar-Law, R; Bray, PG; Brigandi, RA; Davis, CB; Gargallo, DV; Gibbons, P; Gomez-delas-Heras, FM; Gresham, SL; Hart, TK; Hindley, S; Lawrence, RM; Maggs, JL; Mukhtar, A; O'Neill, PM; Park, BK; Roberts, P; Shone, AE; Stocks, PA; Ward, SA; Winstanley, PA | 1 |
Asadollahy, E; Bambal, RB; Bates, M; Berry, N; Biagini, G; Bray, PG; Brigandi, RA; Davies, J; Davis, CB; Gargallo, DV; Gomez-de-Las-Heras, FM; Gresham, SL; Hall, C; Hindley, S; Lander, H; Maggs, JL; Nixon, G; O'Neill, PM; Parapini, S; Park, BK; Rimmer, K; Roberts, P; Shone, AE; Stanford, D; Stocks, PA; Taramelli, D; Vivas, L; Ward, SA; Winstanley, PA | 1 |
Baniecki, ML; Clardy, J; Cortese, JF; Mazitschek, R; Rush, MA; Wiegand, R; Wirth, DF | 1 |
Gómez-Barrio, A; Kouznetsov, VV | 1 |
Masseno, V; Muriithi, S; Nzila, A | 1 |
Bertinaria, M; Croft, SL; Crosetti, M; Fruttero, R; Gasco, A; Guglielmo, S; Rolando, B; Yardley, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Biot, C; Brun, R; Chavain, N; Davioud-Charvet, E; Friebolin, W; Herold-Mende, C; Lanzer, M; Maes, L; Pradines, B; Tóth, K; Wang, Y; Wenzel, NI; Yardley, V | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Anstey, NM; Chalfein, F; Kenangalem, E; Marfurt, J; Piera, KA; Price, RN; Russell, B; Tjitra, E | 1 |
Anstey, NM; Chalfein, F; Ebsworth, EP; Kenangalem, E; Marfurt, J; Piera, KA; Prasetyorini, B; Price, RN; Ratcliff, A; Russell, B; Siswantoro, H; Tjitra, E; Wuwung, M | 1 |
Andrews, KT; Anstey, NM; Chalfein, F; Fairlie, DP; Kenangalem, E; Marfurt, J; Piera, KA; Prayoga, P; Price, RN; Tjitra, E; Wabiser, F | 1 |
Aragno, C; Bertinaria, M; Carvalho, LJ; Fruttero, R; Gasco, A; Giorgis, M; Guglielmo, S; Martins, YC; Parapini, S; Rolando, B; Taramelli, D | 1 |
Chandrashekar, G; Chatterji, D; Meng, L; Robinson, K; Zhu, S | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chibale, K; Gut, J; Masimirembwa, CM; Ongarora, DS; Rosenthal, PJ | 1 |
Alpert, TD; Jez, JM; Lee, SG | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bartolommei, G; Basilico, N; Brindisi, M; Brogi, S; Butini, S; Camodeca, C; Campiani, G; Fiorini, I; Gabellieri, E; Gemma, S; Gualdani, R; Habluetzel, A; Kukreja, G; Kunjir, S; Lamponi, S; Lucantoni, L; Martin, RE; Moncelli, MR; Novellino, E; Savini, L; Summers, RL; Tadini-Buoninsegni, F; Taramelli, D; Valoti, M | 1 |
de Dios, A; Gorka, AP; Roepe, PD | 1 |
Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
Barteau, S; Chibale, K; Gut, J; Heudi, O; Kameni-Tcheudji, J; Mugumbate, GC; Njoroge, M; Rosenthal, PJ; Streckfuss, J; Tukulula, M | 1 |
Avery, VM; Sykes, ML | 1 |
Egan, TJ; Hunter, R; Joshi, MC; Smith, PJ; Taylor, D; Wicht, KJ | 1 |
Anh Ngoc, T; Egan, TJ; Imai, K; Inokuchi, T; Kaiser, M; Kiguchi, R; Wang, MQ; Wang, N; Wicht, KJ | 1 |
4 review(s) available for amodiaquine hydrochloride and chloroquine
Article | Year |
---|---|
Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation.
Topics: Aminoquinolines; Animals; Antimalarials; Drug Design; Humans; Plasmodium | 2009 |
Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
Topics: Antimalarials; Crystallization; Drug Resistance; Heme; Hemeproteins; Humans; Malaria, Falciparum; Molecular Structure; Plasmodium falciparum; Quinolines | 2013 |
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
41 other study(ies) available for amodiaquine hydrochloride and chloroquine
Article | Year |
---|---|
The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.
Topics: Amodiaquine; Animals; Chloroquine; Fluorine; Molecular Structure; Oxidation-Reduction; Plasmodium falciparum; Structure-Activity Relationship | 1994 |
Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Heme; Humans; Models, Molecular; Plasmodium falciparum | 1997 |
New 4-aminoquinoline Mannich base antimalarials. 1. Effect of an alkyl substituent in the 5'-position of the 4'-hydroxyanilino side chain.
Topics: Aniline Compounds; Animals; Antimalarials; Inhibitory Concentration 50; Malaria; Male; Mannich Bases; Mice; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 1999 |
Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines.
Topics: Aniline Compounds; Animals; Antimalarials; Cells, Cultured; Drug Resistance; Female; Humans; Macrophages, Peritoneal; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2001 |
Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Crystallography, X-Ray; Malaria; Male; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Structure-Activity Relationship | 2003 |
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Hydrazones; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship | 2006 |
Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.
Topics: Animals; Antimalarials; Colorimetry; Crystallization; Drug Evaluation, Preclinical; Heme; Hemeproteins; Plasmodium falciparum; Polysorbates; Reproducibility of Results | 2007 |
Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Antagonism; Drug Combinations; Drug Interactions; Drug Resistance; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes; Tritium | 2007 |
Synthesis and antimalarial activity of new analogues of amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Cell Line; Chromatography, High Pressure Liquid; Female; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Mice; Plasmodium berghei | 2008 |
Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
Topics: Animals; Antimalarials; Chloroquine; Humans; Inhibitory Concentration 50; Life Cycle Stages; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Schizonts; Time Factors | 2008 |
Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
Topics: Amides; Animals; Antimalarials; Carbamates; Cell Line; Female; Humans; Malaria; Mice; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2008 |
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Cell Line, Tumor; Chloroquine; Drug Resistance; Drug Therapy, Combination; Glutathione Reductase; Humans; In Vitro Techniques; Malaria; Mice; Mice, Inbred BALB C; Naphthalenes; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2008 |
Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein.
Topics: Antimalarials; Binding Sites; Chromatography, Affinity; Circular Dichroism; Humans; Molecular Structure; Orosomucoid; Protein Binding; Serum Albumin; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship | 2008 |
Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Blotting, Western; Chloroquine; Endocytosis; Erythrocytes; Hemoglobins; Humans; Mefloquine; Peroxidase; Phenanthrenes; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Quinolines | 2008 |
Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles.
Topics: Animals; Antimalarials; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Salmonella typhimurium; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Tetraoxanes | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
Topics: Adolescent; Age Distribution; Amodiaquine; Animals; Antimalarials; Chloroquine; Confidence Intervals; Drug Resistance; Drug Tolerance; Female; Follow-Up Studies; Humans; Inhibitory Concentration 50; Male; Outpatients; Parasitemia; Plasmodium vivax; Prospective Studies; Recurrence; Rural Health; Time Factors; Treatment Failure; Treatment Outcome | 2009 |
Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Benzylamines; Cytochrome P-450 Enzyme Inhibitors; Dogs; Drug Evaluation, Preclinical; Drug Resistance; Female; Haplorhini; Heme; Humans; Malaria; Mice; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Structure-Activity Relationship | 2009 |
Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Cell Survival; Chloroquine; Dogs; Drug Resistance; Female; Haplorhini; Hepatocytes; Humans; In Vitro Techniques; Malaria; Male; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Structure-Activity Relationship | 2009 |
Colorimetric high-throughput screen for detection of heme crystallization inhibitors.
Topics: Animals; Antimalarials; Colorimetry; Crystallization; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heme; Hemeproteins; Plasmodium falciparum | 2009 |
In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid.
Topics: Adjuvants, Pharmaceutic; Animals; Antimalarials; Parasitic Sensitivity Tests; Plasmodium falciparum; Probenecid; Verapamil | 2009 |
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
Topics: Amodiaquine; Animals; Anthelmintics; Antiprotozoal Agents; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Leishmania donovani; Macrophages; Mice; Molecular Structure; Plasmodium falciparum | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA.
Topics: Aminoquinolines; Antimalarials; Antineoplastic Agents; Cell Line, Tumor; DNA; Drug Resistance; Drug Screening Assays, Antitumor; Hemeproteins; Humans; Mannich Bases; Plasmodium falciparum; Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Inhibitory Concentration 50; Naphthyridines; Plasmodium falciparum; Plasmodium vivax | 2010 |
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Female; Humans; Indonesia; Malaria; Male; Middle Aged; Plasmodium malariae; Plasmodium ovale; Treatment Outcome; Young Adult | 2011 |
Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
Topics: Drug Resistance, Multiple, Bacterial; Histone Deacetylase Inhibitors; Hydroxamic Acids; Microbial Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Vorinostat | 2011 |
Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria.
Topics: Amodiaquine; Animals; Antiprotozoal Agents; Aorta, Thoracic; Chemistry, Physical; Malaria, Cerebral; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide Donors; Oxadiazoles; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship | 2011 |
Febrifugine analogue compounds: synthesis and antimalarial evaluation.
Topics: Animals; Antimalarials; Aotus trivirgatus; Drug Evaluation, Preclinical; Malaria; Piperidines; Plasmodium falciparum; Quinazolines | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Benzoheterocyclic amodiaquine analogues with potent antiplasmodial activity: synthesis and pharmacological evaluation.
Topics: Amodiaquine; Animals; Antimalarials; Benzimidazoles; Benzothiazoles; Benzoxazoles; Cell Line; Drug Resistance, Microbial; Heterocyclic Compounds; Plasmodium falciparum; Pyridines; Rats; Structure-Activity Relationship | 2012 |
Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine.
Topics: Aminoquinolines; Amodiaquine; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Methyltransferases; Plasmodium falciparum; Protein Structure, Tertiary | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents.
Topics: Animals; Antimalarials; Benzoxazines; Cell Line; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Molecular Mimicry; Quinazolines; Spectrometry, Mass, Electrospray Ionization | 2012 |
Tetrazole-based deoxyamodiaquines: synthesis, ADME/PK profiling and pharmacological evaluation as potential antimalarial agents.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Binding Sites; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Resistance; Half-Life; Humans; Microsomes, Liver; Molecular Docking Simulation; Plasmodium falciparum; Protein Structure, Tertiary; Rats; Structure-Activity Relationship; Tetrazoles | 2013 |
In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.
Topics: Antimalarials; Dose-Response Relationship, Drug; Hemeproteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Triazoles | 2013 |
Synthesis, β-haematin inhibition, and in vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo[3,2-c]quinolines with various substituents at C2, C6, and N11.
Topics: Animals; Antimalarials; Cell Line; Cell Survival; Hemin; Humans; Indole Alkaloids; Indoles; Mice; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quinolines; Rats; Structure-Activity Relationship | 2014 |